It's nothing to laugh about: Understanding disorders of emotional expression

Consultant Pharmacist

Volumn 22, Issue 9, 2007, Pages 732-742

  Martin, Caren McHenry ^a  

^a NONE

Author keywords

Dextromethorphan; Emotional lability; Glutamate; Involuntary emotional expression disorder; Pathologic laughing and crying; Pseudobulbar affect; Pseudobulbar palsy; Quinidine; Serotonin

Indexed keywords

ANTIDEPRESSANT AGENT; DEXTROMETHORPHAN; LEVODOPA; N METHYL DEXTRO ASPARTIC ACID; QUINIDINE; SEROTONIN;

AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL RESEARCH; EMOTION; EMOTIONAL DISORDER; HUMAN; MENTAL INSTABILITY; NEUROTRANSMITTER RELEASE; PATHOLOGICAL CRYING; PATHOLOGICAL LAUGHTER; PSEUDOBULBAR PALSY; REVIEW; SYMPTOMATOLOGY;

EID: 34548785573     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: 10.4140/TCP.n.2007.732     Document Type: Review

References (26)

1. Arciniegas DB, Lauterbach EC, Anderson KE. The differential diagnosis of pseudobulbar affect (PBA). Distinguishing PBA among disorders of mood and affect. Proceedings of a roundtable meeting. CNS Spectr 2005;10:1-14.
2. Dark FL, McGrath JJ, Ron MA. Pathological laughing and crying. Aust N Z J Psychiatry 1996;30:472-9.
3. Wilson SA. Some problems in neurology. II: pathological laughing and crying. J Neurol Psychopathol 1924;IV:299-333.
4. Andersen G, Ingeman-Nielsen M, Vestergaard K et al. Pathoanatomic correlation between post-stroke pathological crying and damage to brain areas involved in serotonergic neurotransmission. Stroke 1994;25:1050-2.
5. Murai T, Barthel H, Berrouschot J et al. Neuroimaging of serotonin transporters in post-stroke pathological crying. Psychiatry Res 2003;123:207-11.
6. Davidson RJ, Irwin W. The functional neuroanatomy of emotion and affective style. Trends Cogn Sci 1999;3:11-21.
7. Rabins PV, Arciniegas DB. Pathophysiology of involuntary emotional expression disorder. CNS Spectr 2007;12(suppl S):S17-S22.
8. Parvizi J, Anderson SW, Martin CO et al. Pathological laughter and crying. A link to the cerebellum. Brain 2001;124:1708-19.
9. Arciniegas DB, Lauterbach EC, Anderson KE et al. The differential diagnosis of pseudobular affect (PBA). Distinguishing PBA among disorders of mood and affect. Roundtable monograph supplement. CNS Spectr 2005;10:1-14.
10. Cummings JL, Arciniegas DB, Brooks BR et al. Defining and diagnosing involuntary emotional expression disorder. CNS Spectr 2006;11:1-7.
11. Lawson IR, MacLeod RD. The use of imipramine ("Tofranil") and other psychotropic drugs in organic emotionalism. Br J Psychiatry 1969;115:281-5.
12. Sniffer RB, Herndon RM, Rudick RA. Treatment of pathologic laughing and weeping with amitriptyline. N Engl J Med 198S;312: 1480-2.
13. Andersen G, Vestergaard K, Riis JO. Citalopram for post-stroke pathological crying. Lancet 1993;342:837-9.
14. Burns A, Russell E, Stratton-Powell H et al. Sertraline in stroke-associated lability of mood. Int J Geriatr Psychiatry 1999;14:681-5.
15. Muller U, Murai T, Bauer-Wittmund T et al. Paroxetine versus Citalopram treatment of pathological crying after brain injury. Brain Inj 1999;13:805-11.
16. Udaka F, Yamao S, Nagata H et al. Pathologic laughing and crying treated with levodopa. Arch Neurol 1984;41:1095-6.
17. Klein M, Musacchio JM. High affinity dextromethorphan binding sites in guinea pig brain. Effect of sigma ligands and other agents. J Pharmacol Exp Ther 1989;251:207-15.
18. Pope LE, Khalil MH, Berg JE et al. Pharmacokinetics of dextromethorphan after single or multiple dosing in combination with quinidine in extensive and poor metabolizers. J Clin Pharmacol 2004;44:1132-42.
19. Brooks BR, Thisted RA, Appel SH et al. Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial. Neurology 2004;63:1364-70.
20. Panitch HS, Thisted RA, Smith RA et al. Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis. Ann Neurol 2006;59:780-7.
21. Zhang Y, Britto MR, Valderhaug KL et al. Dextromethorphan: enhancing its systemic availability by way of low-dose, quinidine-mediated inhibition of cytochrome P4502D6. Clin Pharmacol Ther 1992;51:647-55.
22. Rhoden DM. Antiarrhythmic drugs, in Goodman and Gilman's The pharmacological basis of therapeutics. Hardman J, Limbird L, Molinoff P, eds. New York, NY: McGraw-Hill; 1996:839-74.
23. Zenvia™ for involuntary emotional expression disorder fact sheet, available at http://www.avanir.com/media/pdf/Zenvia_Fact_Sheet.pdf. Accessed July 15, 2007.
24. Diagnostic and statistical manual of mental disorders. 4th ed. Text rev. Washington, DC: American Psychiatric Association; 2000.
25. Schiffer R, Pope LE. Review of pseudobulbar affect including a novel and potential therapy. J Neuropsychiatry Clin Neurosci 2005;17:447-54.
26. Cummings JL. Involuntary emotional expression disorder: definition, diagnosis, and measurement scales. CNS Spectr 2007;12 (suppl S):S11-S16.